Ironwood Pharmaceuticals reported $17.37M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.


Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 40.21M 12.43M Jun/2025
Agios Pharmaceuticals USD -112020000 22.73M Jun/2025
Almirall EUR 35.8M 37.9M Mar/2025
Alnylam Pharmaceuticals USD -35358000 6.24M Jun/2025
Amarin USD -13630000 197K Mar/2025
Ardelyx USD -19080000 23.76M Jun/2025
Astellas Pharma JPY 90.42B 29.86B Jun/2025
AstraZeneca USD 3.13B 275M Jun/2025
Charles River Laboratories USD 71.42M 35.44M Jun/2025
Exact Sciences USD -57000 100.93M Jun/2025
Halozyme Therapeutics USD 204.94M 61.11M Jun/2025
Incyte USD 558.01M 323.82M Jun/2025
Ironwood Pharmaceuticals USD 17.37M 4.14M Sep/2024
MacroGenics USD -36150000 21.67M Jun/2025
Moderna USD -818000000 146M Jun/2025
Myriad Genetics USD 6.2M 2.1M Dec/2024
Pacira USD -1927000 10.63M Jun/2025
PTC Therapeutics USD -71052000 1B Jun/2025
Sarepta Therapeutics USD 153.64M 537.16M Jun/2025
Takeda JPY 150.63B 257.93B Jun/2025
Ultragenyx Pharmaceutical USD -114004000 35.77M Jun/2025